| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 142, 1449-1457, Copyright © 1993 by American Society for Investigative Pathology
REVIEWS |
AJ Rozemuller, RA Roos, GT Bots, W Kamphorst, P Eikelenboom and WE Van Nostrand
Department of Pathology, Free University Hospital, Amsterdam, The Netherlands.
Brain amyloidosis with abundant beta/A4 protein deposition in plaques and cortical and meningeal vessels is found in Alzheimer's disease (AD) and hereditary cerebral hemorrhage with amyloidosis-Dutch type (HCHWA- D). In contrast to AD, no neuritic pathology or classical congophilic plaques are found in HCHWA-D. Unlike most AD cases, the congophilic angiopathy in HCHWA-D is very severe. It is still unknown whether beta/A4 deposits in plaques and vessels have the same origin. In this study, we have used frozen cortical tissue of HCHWA-D and AD patients to investigate the beta/A4 amyloid protein and the amyloid precursor protein (APP) in different types of plaques and congophilic angiopathy. Immunohistochemical staining was conducted using antibodies against synthetic beta/A4 proteins and antibodies against APP including MAbP2- 1, a monoclonal antibody against purified protease nexin-2, which is the secreted form of APP. In contrast to immunohistochemical studies on formalin-fixed, paraffin-embedded tissue, frozen tissue of HCHWA-D patients revealed a very high number of beta/A4 plaques resembling AD. All plaques were of the diffuse type. Double-staining with MabP2-1 and beta/A4 antisera revealed: 1) the presence of APP immunoreactivity in classical plaques and transitional forms; 2) the absence of APP immunoreactivity in diffuse plaques in HCHWA-D and AD; and 3) pronounced APP immunoreactivity in congophilic vessels in HCHWA-D in contrast to weak APP staining in congophilic vessels in AD. Together these findings suggest that: a) the presence of APP in plaques is related to neuritic changes; b) different processes occur in amyloid formation in plaques and vessels; and c) differences exist between the process of amyloid formation in HCHWA-D and AD.
This article has been cited by other articles:
![]() |
T. Yamashita, Y. Ando, M. Ueda, M. Nakamura, S. Okamoto, M. E. Zeledon, T. Hirahara, T. Hirai, A. Ueda, Y. Misumi, et al. Effect of liver transplantation on transthyretin Tyr114Cys-related cerebral amyloid angiopathy Neurology, January 8, 2008; 70(2): 123 - 128. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Hoos, M. Ahmed, S. O. Smith, and W. E. Van Nostrand Inhibition of Familial Cerebral Amyloid Angiopathy Mutant Amyloid beta-Protein Fibril Assembly by Myelin Basic Protein J. Biol. Chem., March 30, 2007; 282(13): 9952 - 9961. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Xu, J. Davis, J. Miao, M. L. Previti, G. Romanov, K. Ziegler, and W. E. Van Nostrand Protease nexin-2/amyloid {beta}-protein precursor limits cerebral thrombosis PNAS, December 13, 2005; 102(50): 18135 - 18140. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Miao, F. Xu, J. Davis, I. Otte-Holler, M. M. Verbeek, and W. E. Van Nostrand Cerebral Microvascular Amyloid {beta} Protein Deposition Induces Vascular Degeneration and Neuroinflammation in Transgenic Mice Expressing Human Vasculotropic Mutant Amyloid {beta} Precursor Protein Am. J. Pathol., August 1, 2005; 167(2): 505 - 515. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yanagisawa GM1 Ganglioside and the Seeding of Amyloid in Alzheimer's Disease: Endogenous Seed for Alzheimer Amyloid Neuroscientist, June 1, 2005; 11(3): 250 - 260. [Abstract] [PDF] |
||||
![]() |
J. Davis, F. Xu, R. Deane, G. Romanov, M. L. Previti, K. Zeigler, B. V. Zlokovic, and W. E. Van Nostrand Early-onset and Robust Cerebral Microvascular Accumulation of Amyloid {beta}-Protein in Transgenic Mice Expressing Low Levels of a Vasculotropic Dutch/Iowa Mutant Form of Amyloid {beta}-Protein Precursor J. Biol. Chem., May 7, 2004; 279(19): 20296 - 20306. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. E. Van Nostrand, J. P. Melchor, D. M. Keane, S. M. Saporito-Irwin, G. Romanov, J. Davis, and F. Xu Localization of a Fibrillar Amyloid beta -Protein Binding Domain on Its Precursor J. Biol. Chem., September 20, 2002; 277(39): 36392 - 36398. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. E. VAN NOSTRAND, J. MELCHOR, M. WAGNER, and J. DAVIS Cerebrovascular Smooth Muscle Cell Surface Fibrillar A{beta}: Alteration of the Proteolytic Environment in the Cerebral Vessel Wall Ann. N.Y. Acad. Sci., April 1, 2000; 903(1): 89 - 96. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Melchor and W. E. Van Nostrand Fibrillar Amyloid beta -Protein Mediates the Pathologic Accumulation of Its Secreted Precursor in Human Cerebrovascular Smooth Muscle Cells J. Biol. Chem., March 24, 2000; 275(13): 9782 - 9791. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Davis-Salinas and W. E. Van Nostrand Amyloid beta-Protein Aggregation Nullifies Its Pathologic Properties in Cultured Cerebrovascular Smooth Muscle Cells J. Biol. Chem., September 8, 1995; 270(36): 20887 - 20890. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |